Your browser is old and unsupported. Please upgrade!

Ginkgo Bioworks

The world's first organism engineering foundry

Ginkgo Bioworks

The world's first organism engineering foundry

Technology Hardware Bio Tech Y Combinator
What we do: Ginkgo Bioworks speeds up the process of genetically engineering and growing ingredients. We’ve built the first foundry for flexible industrialized organism engineering to develop a wide range of organisms for different markets. Integrating advanced software, robots and biology allow us to rapidly design, build, and test organisms until they meet our specifications.Why it's a big deal: Ginkgo led an $8M DOE project to engineer microbes that utilize single-carbon molecules. This technology is being used to capture natural gas being flared in North Dakota, and it could eventually lead to microbes converting these single-carbon compounds into fuel. Clearly, genetic engineering has immense potential to shape the future of this planet. Nature's biodiversity holds answers to challenges in health, energy, food, materials, and more. Ginkgo engineers develop new organisms that replace technology with biology, leading to 50% reductions in production costs for their clients. With contracts already signed for $10M in annual royalties, it's no wonder Ginkgo was able to pull in $9M from Series A financing. Ginkgo is expanding the role of biology in our world, uniting the creative aspects of biology and technology.
Barry Canton
  • About
  • Updates 0
  • Reviews0
  • Ask a Question 7

Why you may want to support us...

1 Contracts signed for $10 million in annual royalties
2 Reduce production costs for customers by 50%
3 Grow ingredients in about 10 days
4 15 PhD’s and two MIT professors on staff
5 Raised $9 Million in Series A Financing
6 First biotech startup to go through Y Combinator
we've raised $719,000,000 since our founding

Our team

Barry Canton
Barry has a PhD from MIT in Biological Engineering. He studied mechanical engineering at University College Dublin.
Tom Knight
An MIT Professor, Tom has worked in computer science research for 40+ years. He has founded several computer tech companies.
Reshma Shetty
Reshma was a biochemistry researcher at University of Cambridge. She has a PhD. in biological engineering from MIT after getting her B.S in Comp. Sci.
Austin Che
Austin studied Psychology and Computer Science at Stanford. He has a PhD. in Computer Science and Synthetic Biology from MIT.
Jason Kelly
Jason has a PhD. in Biological Engineering from MIT. As a graduate student, he founded science information portal OpenWetWare.org.

In the news

Why organism engineering could be a foodie’s dream come true
By taking advantage of software-directed robots, the plan is to scale up the production of engineered organisms that could eventually be used to make anything from designer fragrances to cheap biofuels.
May 27, 2015 @ washingtonpost.com
Manufacturing’s cutting edge — custom organisms
Ginkgo is part of a field called “synthetic biology” that holds immense promise — but also freaks people out. It involves writing genetic code and inserting it into simple organisms to change their function.
March 22, 2015 @ bostonglobe.com
Ginkgo Bioworks Raises $9M to ‘Engineer’ Food Flavors, Fragrances
If microbes could be programmed as easily as software, the varieties of molecules used in foods, fragrances and other products would multiply–a vision that Ginkgo Bioworks Inc. aims to achieve after raising $9 million in Series A venture financing.
March 18, 2015 @ blogs.wsj.com
Why The First YC-Backed Biotech Company May Just Be The Future Of Pharma
Gingko Bioworks sounds kind of like a mad science lab of the future. The Boston-based biotech company is currently working on a project with DARPA to treat antibiotic-resistant germs, using designer microbes to convert CO2 emissions into fuel and is somehow making yeast smell like roses.
July 16, 2014 @ techcrunch.com
technology hardware bio tech y combinator



Ask a Question

Overview
Story
Traction
Investor Q&A
Financials
Risks
Details
← Back
About us
Our Profile
Jobs
Press
Blog
Charter
Investors
Getting Started
Risks
Earning Returns
Funds
Give/Get $2500
Founders
Raise Money
FAQ
Legal Primer
Deals
Fundraising Playbook
Say Hello
hello@wefunder.com
Twitter
Facebook
Instagram
888-546-0325
San Francisco
wefunder.com/ginkgobioworks is managed by Wefunder Inc. Wefunder Inc. runs wefunder.com and is the parent company of Wefunder Advisors LLC and Wefunder Portal LLC. Wefunder Advisors is an exempt reporting adviser that advises SPVs used in Reg D offerings. Wefunder Portal is a funding portal (CRD #283503) that operates sections of wefunder.com where some Regulation Crowdfunding offerings are made. Wefunder, Inc. operates sections of wefunder.com where some Regulation D and A offerings are made. Wefunder, Inc. is not regulated as either a broker-dealer or funding portal and is not a member of FINRA. By using wefunder.com, you accept our Terms & Privacy Policy. If investing, you accept our Investor Agreement. You may also view our Privacy Notice.
Wefunder, Inc., Wefunder Advisors LLC, and Wefunder Portal LLC do not review user-generated content beyond what's required by US law. Some user-generated content, including investor biographical information, may not be accurate.

Already have a Wefunder account? Login

Don't have a Wefunder account? Signup

Privacy: We won’t share your data with Facebook without your explicit permission.
— or —
Explore Activity FAQ Raise Money
Login Sign Up